December 20, 2004 - ASM Letter to Senator Specter The ASM sent a letter to Senator Arlen Specter, Chair of the Senate Appropriations Subcommittee on Labor, Health and Human Services and Education, thanking him for his support of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).
October 12, 2004 - ASM Submits Comments to CDC on Vaccine Safety On October 12, the ASM submitted comments to the Centers for Disease Control and Prevention (CDC) in response to a request for comments that was published in the Morbidity and Mortality Weekly Report (MMWR) regarding the current state of CDC’s Vaccine Safety Program.
August 16, 2004 - ASM Letter to Congress Requesting Increased Funding for NSF The ASM sent a letter to each member of Congress urging them to increase funding above the House Appropriations Committee’s level for the National Science Foundation. The House Appropriations Committee’s mark would provide $5.47 billion for the NSF in FY 2005, a decrease of $111 million, or 2 percent, below the FY 2004 funding level, and a decrease of $278 million, or 5 percent, below the President’s FY 2005 budget request.
August 4, 2004 - Establishing a regulatory limit on Listeria monocytogenes The ASM submitted a statement in response to the Food and Drug Administration (FDA) notice requesting comments on the petition asking that theFDA amend the current regulations in 21 CFR part 109, “Unavoidable Contaminants in Food for Human Consumption and Food-Packaging Material,” to establish a regulatory limit on Listeria monocytogenes of 100 colony forming units per gram in foods that do not support growth of the microorganism.
August 4, 2004 - Water Quality Criteria for Bacteria for Coastal and Great Lakes Waters The ASM submitted comments in response to the Environmental Protection Agency (EPA) notice requesting comments on the proposed rule to establish water quality criteria for bacteria for coastal and Great Lakes waters that specific States and Territories have designated for swimming, bathing, surfing, or similar water contact activities and for which the State or Territory does not have in place EPA-approved bacteria criteria that are as protective of human health as EPA’s 1986 recommended bacteria criteria.
July 30, 2004 – ASM Comments on 2004 Clinical Laboratory Fee Schedule On July 30, ASM submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to Publication 100-20, Change Request 2959, 2004 Annual [Changes] for Clinical Laboratory Fee Schedule and Laboratory Services Subject to Reasonable Charge Payment Methodology.